No abstract available
MeSH terms
-
Antigens, CD / analysis
-
Antigens, Differentiation, Myelomonocytic / analysis
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Bone Marrow / pathology
-
Cytarabine / administration & dosage
-
Etoposide / administration & dosage
-
Fatal Outcome
-
Humans
-
Idarubicin / administration & dosage
-
Immunization, Secondary
-
Leukemia, Myelomonocytic, Chronic / diagnosis
-
Leukemia, Myelomonocytic, Chronic / drug therapy
-
Leukemia, Myelomonocytic, Chronic / pathology*
-
Leukemia, Myelomonocytic, Chronic / radiotherapy
-
Leukemic Infiltration / diagnosis*
-
Leukemic Infiltration / drug therapy
-
Leukemic Infiltration / etiology
-
Leukemic Infiltration / pathology
-
Leukemic Infiltration / radiotherapy
-
Leukosialin / analysis
-
Male
-
Middle Aged
-
Radiotherapy, Adjuvant
-
Shock, Septic / etiology
-
Skin / pathology*
-
Tetanus Toxoid / administration & dosage
-
Tetanus Toxoid / adverse effects*
Substances
-
Antigens, CD
-
Antigens, Differentiation, Myelomonocytic
-
CD68 antigen, human
-
Leukosialin
-
SPN protein, human
-
Tetanus Toxoid
-
Cytarabine
-
Etoposide
-
Idarubicin